PROSENZA: Prospective Multi-Centre Study of Prognostic Factors in mCRPC Patients Treated With Enzalutamide.

Clinical trial NCT02922218 · UNKNOWN

Trial details

NCT number: NCT02922218
Sponsor: Centro Nacional de Investigaciones Oncologicas CARLOS III
Status: UNKNOWN
Study type: OBSERVATIONAL

Advanced Prostate Cancer Castration Resistant Enzalutamide

Start date: 2016-06-01
Primary completion: 2020-01-01
Enrollment: 187

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.